• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种诃子[诃子(诃黎勒)]剂型的肠道转运时间比较评价

A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz].

作者信息

Jirankalgikar Yogesh M, Ashok B K, Dwivedi Rambabu R

机构信息

Ph.D. Scholar, Department of Basic Principles, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat, India.

出版信息

Ayu. 2012 Jul;33(3):447-9. doi: 10.4103/0974-8520.108866.

DOI:10.4103/0974-8520.108866
PMID:23723658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3665098/
Abstract

Haritaki is praised as the best salutary drug which can be used in almost all ages of human life and is reputed for its Anulomana property. In Ayurveda, it has been mentioned that fruits of Haritaki when used in different forms give different type of actions. As the prime therapeutic utility of Haritaki is Anulomana, in the present study, two dosage forms of Haritaki fruits namely Churna and Vati were evaluated for intestinal transit time to evaluate its effect in two different dosage forms. Mature fruits were collected, authenticated, and processed as per classics to get Churna and Vati. Test drugs were administered in the dose of 550 mg/kg and evaluation on intestinal transit time was carried out by adopting kaolin expulsion test in mice. The results show that both the dosage forms of Haritaki significantly shortened intestinal transit time and between them Churna form is found to be better.

摘要

诃子被誉为最佳的滋补药物,几乎适用于人类生命的所有年龄段,并因其顺气特性而闻名。在阿育吠陀医学中,提到诃子果实以不同形式使用时会产生不同类型的作用。由于诃子的主要治疗效用是顺气,在本研究中,对诃子果实的两种剂型即散剂和丸剂进行了肠转运时间评估,以评价其在两种不同剂型中的效果。收集成熟果实,按照经典方法进行鉴定和加工,制成散剂和丸剂。以550毫克/千克的剂量给药受试药物,并通过采用高岭土排出试验对小鼠进行肠转运时间评估。结果表明,诃子的两种剂型均显著缩短了肠转运时间,且其中散剂效果更佳。

相似文献

1
A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz].两种诃子[诃子(诃黎勒)]剂型的肠道转运时间比较评价
Ayu. 2012 Jul;33(3):447-9. doi: 10.4103/0974-8520.108866.
2
Assessment of , an ayurvedic formulation on intestinal transit time in swiss albino mice.评估一种阿育吠陀配方对瑞士白化小鼠肠道转运时间的影响。 (你提供的原文似乎不完整,少了具体的阿育吠陀配方名称等关键信息)
Ayu. 2018 Jan-Mar;39(1):46-49. doi: 10.4103/ayu.AYU_33_18.
3
Haritaki (Chebulic myrobalan) and its varieties.诃子(诃梨勒)及其变种。
Ayu. 2013 Jul;34(3):331-4. doi: 10.4103/0974-8520.123139.
4
A comprehensive review on the diverse pharmacological perspectives of Retz.关于雷茨(Retz)不同药理学观点的全面综述。
Heliyon. 2022 Aug 14;8(8):e10220. doi: 10.1016/j.heliyon.2022.e10220. eCollection 2022 Aug.
5
Hypolipidemic activity of haritaki (terminalia chebula) in atherogenic diet induced hyperlipidemic rats.诃子对致动脉粥样硬化饮食诱导的高脂血症大鼠的降血脂活性
J Adv Pharm Technol Res. 2010 Apr;1(2):229-35.
6
Evaluation of the anti-hyperlipidemic effects of in high fat diet fed rats: Studies with two combinations.高脂饮食喂养大鼠中[具体物质]抗高脂血症作用的评价:两种组合的研究
Ayu. 2022 Jul-Sep;43(3):98-104. doi: 10.4103/ayu.AYU_74_19. Epub 2023 Oct 9.
7
Experimental evaluation of antipyretic and analgesic activities of Amalakyadi Gana: An Ayurvedic formulation.阿玛拉卡迪加纳(一种阿育吠陀配方)的解热和镇痛活性的实验评估
Ayu. 2015 Apr-Jun;36(2):220-4. doi: 10.4103/0974-8520.175554.
8
Extraction, phytochemical characterization and anti-cancer mechanism of Haritaki churna: An ayurvedic formulation.诃黎勒散的提取、植物化学特征及抗癌机制:一种阿育吠陀制剂。
PLoS One. 2023 May 31;18(5):e0286274. doi: 10.1371/journal.pone.0286274. eCollection 2023.
9
Triphala Churna-A Traditional Formulation in Ayurveda Mitigates Diabetic Neuropathy in Rats.三果木粉——阿育吠陀中的一种传统配方可减轻大鼠的糖尿病性神经病变
Front Pharmacol. 2021 Jun 3;12:662000. doi: 10.3389/fphar.2021.662000. eCollection 2021.
10
Evaluation of intestinal transit time of root and leaves of Ipomea sepiaria.海鹤菜根与叶的肠道转运时间评估
Ayu. 2013 Oct;34(4):430-2. doi: 10.4103/0974-8520.127729.

引用本文的文献

1
Ayurveda management of post TURP urethral stricture: A case report.经尿道前列腺电切术后尿道狭窄的阿育吠陀疗法:一例报告。
J Ayurveda Integr Med. 2025 Mar-Apr;16(2):101084. doi: 10.1016/j.jaim.2024.101084. Epub 2025 Mar 17.
2
Improved quality of life of a patient with refractory aggressive Natural Killer/ T-cell lymphoma (NKTCL) on adjunct Ayurvedic treatment protocol: A case report of ten-years follow-up.辅助阿育吠陀治疗方案改善难治性侵袭性自然杀伤/T细胞淋巴瘤(NKTCL)患者的生活质量:一项十年随访的病例报告
J Ayurveda Integr Med. 2024 Nov-Dec;15(6):100968. doi: 10.1016/j.jaim.2024.100968. Epub 2024 Nov 22.
3
Randomized Double-Blind Placebo-Controlled Supplementation with Standardized Fruit Extracts Reduces Facial Sebum Excretion, Erythema, and Wrinkle Severity.标准化水果提取物的随机双盲安慰剂对照补充剂可减少面部皮脂分泌、红斑和皱纹严重程度。
J Clin Med. 2023 Feb 17;12(4):1591. doi: 10.3390/jcm12041591.
4
Efficacy of whole system ayurveda protocol in irritable bowel syndrome - A Randomized controlled clinical trial.全系统阿育吠陀疗法治疗肠易激综合征的疗效——一项随机对照临床试验
J Ayurveda Integr Med. 2023 Jan-Feb;14(1):100592. doi: 10.1016/j.jaim.2022.100592. Epub 2022 Nov 9.